Given the growing number of people taking this drug who have no cardiovascular disease or who are not classified as obese, we suggest that cardiac structure and function be carefully evaluated in previous and ongoing clinical studies. Dycks study comes on the heels of a commentary published in the November issue of The Lancet by an international team of researchers from the U of A, McMaster, and Louisiana State University who examined emerging research showing that up to 40 percent of the weight lost by people using weight-loss drugs is actually muscle
Microneedle-Mediated Delivery of Copper Peptide (2015) (PubMed) Miller et al
GLP-1 plays an immunomodulatory role
Corticosteroids suppress inflammation effectively but don't address underlying tissue damage and can degrade cartilage over repeated use
3.4 Poor outcomes and immunosuppressive drugs administered during follow-up in patients with AAV During follow-up after diagnosis, among the 71 patients, 6 (8.5%) died, and 17, four, and one had ever experienced and suffered from ESKD, CVA, and ACS, respectively
The bottom line Copper peptides and GHK-Cu sit at an interesting intersection: enough early science to be genuinely exciting, not yet enough to call them proven